Tenets for developing quality measures for ambulatory clinical pharmacy services

Pharmacotherapy

Volumn 31, Issue 7, 2011, Pages

  McBane, Sarah ^a   Trewet, CoraLynn B ^a   Havican, S Nadra ^a   Kiser, Katie ^a   Klingel, Christine ^a   Riche, Daniel M ^a   Sease, Julie M ^a   Nau, David P ^a   Zillich, Alan J ^a  

^a American College of Clinical Pharmacy   (United States)

Author keywords

Ambulatory care; Clinical pharmacy services; Pharmacy practice; Quality measures

Indexed keywords

ACCESS TO INFORMATION; AMBULATORY CARE; ANTICOAGULATION; ARTICLE; CHRONIC LUNG DISEASE; CLINICAL PHARMACY; COOPERATION; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEART FAILURE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MEDICAL LITERATURE; PHARMACIST; QUALITY CONTROL;

EID: 79959714579     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.31.7.723     Document Type: Article

References (54)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43. (Pubitemid 20138134)
2. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-66. (Pubitemid 44596195)
3. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001;41:192-9.
4. Patient Protection and Affordable Care Act. HR 3590 §10331(a)(1). U.S. Congress, ed. GovTrack.us (database of federal legislation), 2010.
5. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists-2003. Pharmacotherapy 2003;23:1210-25. (Pubitemid 37158791)
6. Borenstein JE, Graber G, Saltiel E, et al. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy 2003;23:209-16. (Pubitemid 36204018)
7. Bray P, Thompson D, Wynn JD, Cummings DM, Whetstone L. Confronting disparities in diabetes care: the clinical effectiveness of redesigning care management for minority patients in rural primary care practices. J Rural Health 2005;21:317-21. (Pubitemid 41346046)
8. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc 2006;46:133-47. (Pubitemid 46037370)
9. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003) 2008;48:23-31.
10. Carter B, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;169:1996-2002.
11. Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract 2001;14:16-21. (Pubitemid 33605759)
12. Chiquette E, Amato M, Bussey H. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641-7. (Pubitemid 28371187)
13. Cohen V, Jellinek SP, Hatch A, Motov S. Effect of clinical pharmacists on care in the emergency department: a systematic review. Am J Health Syst Pharm 2009;66:1353-61.
14. Coleman EA, Eilertsen TB, Kramer AM, Magid DJ, Beck A, Conner D. Reducing emergency visits in older adults with chronic illness. A randomized, controlled trial of group visits. Eff Clin Pract 2001;4:49-57.
15. Cranor CW, Bunting B, Christenson D. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:173-84.
16. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000;20:1508-8.
17. Fera T, Bluml B, Ellis W. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program. J Am Pharm Assoc 2008;48:181-90.
18. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA 2008;299:2857-67.
19. Griffin BL, Burkiewicz JS, Peppers LR, Warholak TL. International normalized ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic. Am J Health Syst Pharm 2009;66:1218-223.
20. Isetts B, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc 2008;48:203-11.
21. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drugrelated morbidity and achieving therapeutic goals. Arch Intern Med 2003;163:1813-20. (Pubitemid 36960929)
22. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 1997;54:554-8. (Pubitemid 27114432)
23. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006;166:955-64.
24. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973;48:1104-11.
25. Monte S, Slavak EM, Albanese NP, Adelman M, Rao G, Paladino JA. Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration model. J Am Pharm Assoc (2003) 2009;49:200-8.
26. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med 2007;146:714-25. (Pubitemid 351639999)
27. Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy 2010;30:330-8.
28. Strand LM, Cipolle RJ, Morley PC, Frakes MJ. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des 2004;10:3987-4001. (Pubitemid 39591913)
29. Wilt V, Gums J, Ahmed O. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy 1995;14:732-9.
30. Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 2005;127:1515-22. (Pubitemid 46218774)
31. Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2009;(3):CD000072.
32. Lipton H. Pharmacists and health reform: go for it! Pharmacotherapy 2010;30:967-72.
33. The Patient Protection and Affordable Care Act [cited 2010 May 20]. Available from http://democrats.senate.gov/reform/patient-protection-affordable- care-act-as-passed.pdf. Accessed March 21, 2011.
34. U.S. Department of Health and Human Services. Report to Congress: plan to implement a Medicare hospital value-based purchasing program [cited 2010 May 19]. Available from www.cms.hhs.gov/AcuteInpatientPPS/downloads/ HospitalVBPPlanRTCFINALSUBMITTED2007.pdf. Accessed March 21, 2011.
35. Nau DP. Measuring pharmacy quality. J Am Pharm Assoc (2003) 2009;49:154-63.
36. National Committee for Quality Assurance. About NCQA [cited 2010 May 19]. Available from www.ncqa.org/tabid/675/Default.aspx. Accessed March 21, 2011.
37. National Committee for Quality Assurance. HEDIS and quality measurement [cited 2010 May 19]. Available from www.ncqa.org/tabid/59/Default.aspx. Accessed March 21, 2011.
38. National Committee for Quality Assurance (NCQA). What is HEDIS? [cited 2010 May 19]. Available from www.ncqa.org/tabid/187/Default.aspx. Accessed March 21, 2011.
39. Pharmacy Quality Alliance. Mission statement [cited 2010 May 19]. Available from www.pqaalliance.org. Accessed March 21, 2011.
40. Pillittere-Dugan D, Nau DP, McDonough K, Pierre Z. Development and testing of performance measures for pharmacy services. J Am Pharm Assoc (2003) 2009;49:212-9.
41. Carter B. Ambulatory care. In: Brown T, Smith M, eds. Handbook of institutional pharmacy practice. Bethesda, MD: American Society of Hospital Pharmacists, 1992:367-73.
42. Moore L. Escaping the tyranny of the urgent by delivering planned care. Fam Pract Manag 2006;13:37-40. (Pubitemid 43748307)
43. Sipkoff M. Pharmacists can be crucial to medical homes. Manag Care 2008;17:14-5.
44. Currell R, Urquhart C, Wainwright P, Lewis R. Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000;(2):CD002098.
45. Lam A, Rose D. Telepharmacy services in an urban community health clinic system. J Am Pharm Assoc 2009;49:652-9.
46. Elliott RA, Barber N, Clifford S, Horne R, Hartley E. The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines. Pharm World Sci 2008;30:17-23. (Pubitemid 350172641)
47. Crossing the Quality Chasm: A New Health System for the 21st Century. Institute of Medicine, ed. Washington, DC: National Academies Press, 2001.
48. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q 1966;44:166-206.
49. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med 2009;169:1748-55.
50. Munroe WP, Kunz K, Dalmady-Israel C, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997;19:113-23. (Pubitemid 27186443)
51. Okamoto M, Nakahiro R. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001;21:1337-44.
52. Smith M, Bates DW, Bodenheimer T, Cleary T. Why pharmacists belong in the medical home. Health Aff 2010;29:906-13.
53. Farris KB, Kumbera P, Halterman T, Fang G. Outcomes-based pharmacist reimbursement: reimbursing pharmacists for cognitive services part 1. J Manag Care Pharm 2002;8:383-93.
54. Perez A, Doloresco F, Hoffman JM, et al; American College of Clinical Pharmacy. ACCP: economic evaluations of clinical pharmacy services: 2001-2005. Pharmacotherapy 2008;28:285e-323e.